Australia's CSL to start work on immunoglobulin product to treat COVID-19

Australian biotech firm CSL Ltd said on Wednesday it will start local development of an immunoglobulin product to treat serious cases of COVID-19, the disease caused by the novel coronavirus.

from Reuters: Health https://ift.tt/2A4xAkf
via IFTTT

• Tweet
• Share
• Share
• Share
• Share